Should the TRIPS Waiver be expanded to Covid-19 therapeutics and diagnostics?
Wednesday 5th October 2022
0900 Washington DC : 1500 Geneva
WTO members will decide over the next months whether to expand the TRIPS waiver from vaccines to Covid therapeutics and diagnostics. This panel will discuss the implications for innovation, manufacturing and access.
Executive Director, Innovation Council, Switzerland
Professor of Intellectual Property Law, University of Akron, USA and co-founder of the Center for Intellectual Property x Innovation Policy (C-IP2)
Amir Ullah Khan
Research Director at the Centre for Development Policy and Practice in Hyderabad, India
Prof. Bryan Mercurio
Simon F.S. Li Professor of Law at the Chinese University of Hong Kong
Executive Director, Geneva Network